top of page
КЛИНИКА Доктора УСКОВ Logo-2.png

Laser treatment for dry eye syndrome (article)

  • gertnulk
  • 15 авг.
  • 3 мин. чтения

Обновлено: 18 авг.

A modern, safe, and scientifically supported approach at Dr. Uskov’s clinic


Dry eye disease (DED) is one of the most common eye conditions in the modern world. It is accompanied by a sensation of “sand” in the eyes, burning, tearing, light sensitivity, and reduced vision, significantly affecting quality of life.


Today, in addition to traditional therapies (drops, gels, compresses, etc.), laser treatment is gaining popularity and evidence-based support, especially in cases of meibomian gland dysfunction (the primary cause of DED).

At the clinic of international expert Dr. Uskov, a modern, comprehensive approach to dry eye therapy is used, employing laser technologies proven effective in international practice.


A relevant problem


According to the World Health Organization, up to 30% of the population experiences symptoms of dry eyes. The condition is particularly common in:

  • People over 40 years old

  • Contact lens users

  • Office workers and those who spend long hours in front of screens

  • Postmenopausal women

  • Patients after cosmetic or ophthalmologic surgeries

DED can also accompany chronic skin conditions (e.g., rosacea with blepharitis), autoimmune diseases (e.g., Sjögren’s syndrome), and may occur as a side effect of certain medications.


Causes of dry eye disease


DED may result from:

  • Reduced tear production

  • Accelerated tear evaporation (due to lipid layer dysfunction)

  • Inflammation of the eyelid margins and meibomian glands

  • Impaired blinking reflex

A key cause of dry eyes, especially in adults, is meibomian gland dysfunction (MGD), which we treat effectively and safely using laser technologies.


How does a laser help?


Laser and IPL (intense pulsed light) treatments can:

  • Reduce inflammation in the eyelid and lash line

  • Improve drainage and function of the meibomian glands

  • Restore the quality of the tear film lipid layer

  • Reduce bacterial load and demodex (small mites)

  • Decrease manifestations of blepharitis and periocular rosacea

  • Extend the effect of traditional therapies


Treatment course


Consultation and Diagnostics

A comprehensive diagnostic assessment is conducted:

  • Visual examination of eyelid margins and surrounding skin

  • Digital dermatoscopy of the periocular area

  • Symptom analysis and medical history review

  • Based on the results, a personalized therapy protocol is developed, including laser treatment and supportive care if needed.


Procedure

  • Type of treatment: IPL or non-ablative laser with controlled depth

  • Treatment areas: lower eyelid skin, cheek area, occasionally upper eyelid

  • Duration: 10–20 minutes

  • Pain level: minimal, often no anesthesia required

  • Amount of sessions: 3–6 sessions spaced 2–4 weeks apart; some patients notice mild relief after the first session


What to expect


After a course of laser therapy, most patients experience:

  • Reduced burning and discomfort

  • Decreased light sensitivity

  • Elimination of the “sand” sensation in the eyes

  • Improved tear film stability

  • Enhanced meibomian gland function

  • Reduced need for moisturizing eye drops


Safety and expertise


At Dr. Uskov’s clinic:

  • Only certified medical-grade lasers are used

  • Procedures are performed by internationally qualified specialists experienced in periocular care

  • Eye protection (special scleral shields) and dynamic skin cooling are used when necessary

Working around the eyes requires the highest precision and anatomical knowledge, ensuring strict adherence to medical standards.


Recovery and aftercare


After the procedure:

  • Mild skin redness may appear, typically resolving within 1–2 days

  • No rehabilitation is required

  • Avoid direct sun exposure for 5–7 days and use photoprotection (SPF 50+)

  • Follow post-procedure care instructions and continue eye drops if prescribed


Every patient is unique


Treatment outcomes depend on:

  • Severity and cause of dry eye disease

  • Degree of meibomian gland dysfunction

  • Patient age and skin phototype

  • Presence of comorbid conditions (rosacea, seborrheic dermatitis, etc.)

  • Adherence to post-procedure recommendations


Dry eye disease is more than discomfort. It is a chronic condition that, if untreated, can lead to structural eye damage and permanent vision reduction.


 
 
 

© 2025 Laserkliinik OÜ, Александр Усков, Лаура Нульк-Усков

bottom of page